标题
Biomarkers for the Early Detection and Progression of Alzheimer’s Disease
作者
关键词
Alzheimer’s disease, Mild cognitive impairment, Biomarker, Cerebrospinal fluid, Positron emission tomography, Amyloid
出版物
Neurotherapeutics
Volume 14, Issue 1, Pages 35-53
出版商
Springer Nature
发表日期
2016-10-13
DOI
10.1007/s13311-016-0481-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Low Levels of Antibodies Against Phosphorylcholine in Alzheimer's Disease
- (2017) Ulrika K. Eriksson et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid imaging: Past, present and future perspectives
- (2016) Victor L. Villemagne AGEING RESEARCH REVIEWS
- Characterization of tau positron emission tomography tracer [ 18 F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias
- (2016) Kerstin Sander et al. Alzheimers & Dementia
- 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology inMAPTmutation carriers
- (2016) Ruben Smith et al. BRAIN
- Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer's Disease
- (2016) Scott E. Counts et al. Current Alzheimer Research
- Tau imaging in the study of ageing, Alzheimer's disease, and other neurodegenerative conditions
- (2016) Victor L Villemagne et al. CURRENT OPINION IN NEUROBIOLOGY
- Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
- (2016) Konstantinos Chiotis et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients
- (2016) Fabio Di Domenico et al. FREE RADICAL BIOLOGY AND MEDICINE
- Synthesis and quality control of [18F]T807 for tau PET imaging
- (2016) Daniel P. Holt et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)
- (2016) Abbas M. Walji et al. JOURNAL OF MEDICINAL CHEMISTRY
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease
- (2016) Chelsea T. Tiernan et al. NEUROBIOLOGY OF AGING
- Tau PET in Alzheimer disease and mild cognitive impairment
- (2016) Hanna Cho et al. NEUROLOGY
- Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly
- (2016) Jasmeer P. Chhatwal et al. NEUROLOGY
- PET Imaging of Tau Deposition in the Aging Human Brain
- (2016) Michael Schöll et al. NEURON
- Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer’s Disease Patients Measured Using [18F] THK-5351
- (2016) Samuel N. Lockhart et al. PLoS One
- Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
- (2016) Matthew R. Brier et al. Science Translational Medicine
- Immunoadsorption of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients With Mild to Moderate Dementia
- (2016) Petra Hempel et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy
- (2016) Liang Wang et al. JAMA Neurology
- Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease
- (2016) Jennifer S. Yokoyama et al. JAMA Neurology
- Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease
- (2016) Rawan Tarawneh et al. JAMA Neurology
- Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
- (2016) Henrik Zetterberg et al. JAMA Neurology
- Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807
- (2016) Lieven Declercq et al. Molecular Imaging
- An autoradiographic evaluation of AV-1451 Tau PET in dementia
- (2016) Val J. Lowe et al. Acta Neuropathologica Communications
- Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
- (2015) Hlin Kvartsberg et al. Alzheimers & Dementia
- 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
- (2015) Michael W. Weiner et al. Alzheimers & Dementia
- Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research
- (2015) Sid E. O'Bryant et al. Alzheimers & Dementia
- Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
- (2015) Osama Sabri et al. Alzheimers & Dementia
- Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study
- (2015) Massimo S. Fiandaca et al. Alzheimers & Dementia
- Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
- (2015) Kaj Blennow et al. Alzheimers & Dementia
- Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
- (2015) Marta Marquié et al. ANNALS OF NEUROLOGY
- Tau positron emission tomographic imaging in aging and early Alzheimer disease
- (2015) Keith A. Johnson et al. ANNALS OF NEUROLOGY
- Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer’s disease
- (2015) John A. McIntyre et al. AUTOIMMUNITY
- Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease
- (2015) Erik Portelius et al. BRAIN
- Alzheimer’s disease cerebrospinal fluid biomarker in cognitively normal subjects
- (2015) Jon B. Toledo et al. BRAIN
- Imaging β-amyloid using [18F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis
- (2015) Kerstin Heurling et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- [18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease
- (2015) Ryuichi Harada et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PET Quantification of Tau Pathology in Human Brain with 11C-PBB3
- (2015) Y. Kimura et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
- (2015) R. Harada et al. JOURNAL OF NUCLEAR MEDICINE
- Structure-Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer Disease
- (2015) T. Tago et al. JOURNAL OF NUCLEAR MEDICINE
- Antibody drugs for Alzheimer’s show glimmers of promise
- (2015) Sara Reardon NATURE
- Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
- (2015) Sebastian Palmqvist et al. NEUROLOGY
- Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults
- (2015) Corinne Pettigrew et al. NEUROPSYCHOLOGIA
- Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort
- (2015) Maartje I. Kester et al. Alzheimers Research & Therapy
- Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density
- (2015) Craig Curtis et al. JAMA Neurology
- Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
- (2015) Courtney L. Sutphen et al. JAMA Neurology
- Plasma protein biomarkers of Alzheimer’s disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes
- (2015) S J Kiddle et al. Translational Psychiatry
- Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer’s Disease
- (2015) Massimo S. Fiandaca et al. Frontiers in Neurology
- Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer’s Disease and Cerebral Amyloid Angiopathy
- (2015) Jacopo C. DiFrancesco et al. Frontiers in Neurology
- Visualization of regional tau deposits using 3H-THK5117 in Alzheimer brain tissue
- (2015) Laetitia Lemoine et al. Acta Neuropathologica Communications
- MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease
- (2015) Johannes Denk et al. PLoS One
- Longitudinal Assessment of Tau Pathology in Patients with Alzheimer’s Disease Using [18F]THK-5117 Positron Emission Tomography
- (2015) Aiko Ishiki et al. PLoS One
- The cerebrospinal fluid “Alzheimer profile”: Easily said, but what does it mean?
- (2014) Flora H. Duits et al. Alzheimers & Dementia
- Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using 18F-THK5105 PET
- (2014) Nobuyuki Okamura et al. BRAIN
- Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer’s disease and mild cognitive impairment
- (2014) Niklas Mattsson et al. BRAIN
- Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
- (2014) Mirjana Babić et al. CROATIAN MEDICAL JOURNAL
- Role of cholesterol metabolism in the pathogenesis of Alzheimerʼs disease
- (2014) Bernadette Allinquant et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers
- (2014) S. M. Landau et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease
- (2014) Victor L. Villemagne et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Non-stiff anti-amphiphysin syndrome: Clinical manifestations and outcome after immunotherapy
- (2014) Jangsup Moon et al. JOURNAL OF NEUROIMMUNOLOGY
- Metabolomics of Human Brain Aging and Age-Related Neurodegenerative Diseases
- (2014) Mariona Jové et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Radiosynthesis, Photoisomerization, Biodistribution, and Metabolite Analysis of 11C-PBB3 as a Clinically Useful PET Probe for Imaging of Tau Pathology
- (2014) H. Hashimoto et al. JOURNAL OF NUCLEAR MEDICINE
- SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
- (2014) Ann Brinkmalm et al. Molecular Neurodegeneration
- Plasma phospholipids identify antecedent memory impairment in older adults
- (2014) Mark Mapstone et al. NATURE MEDICINE
- Early detection of Alzheimer's disease using PiB and FDG PET
- (2014) Ann D. Cohen et al. NEUROBIOLOGY OF DISEASE
- CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
- (2014) T. Skillback et al. NEUROLOGY
- N-methyl-d-aspartate glutamate receptor (NMDA-R) antibodies in mild cognitive impairment and dementias
- (2014) Stefan Busse et al. NEUROSCIENCE RESEARCH
- Apolipoprotein E Genotype and the Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers for Alzheimer Disease
- (2014) Ronald Lautner et al. JAMA Psychiatry
- Multimodal MRI-based imputation of the Aβ+ in early mild cognitive impairment
- (2014) Duygu Tosun et al. Annals of Clinical and Translational Neurology
- High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types
- (2014) Sarah Doss et al. Annals of Clinical and Translational Neurology
- Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
- (2013) Chun-Fang Xia et al. Alzheimers & Dementia
- Dissecting phenotypic traits linked to human resilience to Alzheimer’s pathology
- (2013) Beatriz G. Perez-Nievas et al. BRAIN
- Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid- 1-42 and Proteins as Alzheimer Disease Biomarkers
- (2013) J.-H. Kang et al. CLINICAL CHEMISTRY
- Positron emission tomography radioligands forin vivoimaging of Aβplaques
- (2013) N. Scott Mason et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- The role of autophagy in neurodegenerative disease
- (2013) Ralph A Nixon NATURE MEDICINE
- Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease
- (2013) C. Sala Frigerio et al. NEUROLOGY
- Lysosomal Network Proteins as Potential Novel CSF Biomarkers for Alzheimer’s Disease
- (2013) Andrea Armstrong et al. NEUROMOLECULAR MEDICINE
- Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
- (2013) Masahiro Maruyama et al. NEURON
- Anti-Chol-1 Antigen, GQ1bα, Antibodies Are Associated with Alzheimer’s Disease
- (2013) Toshio Ariga et al. PLoS One
- Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
- (2013) Tobias Skillbäck et al. Alzheimers Research & Therapy
- Plasma tau levels in Alzheimer's disease
- (2013) Henrik Zetterberg et al. Alzheimers Research & Therapy
- Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study
- (2012) Milos D. Ikonomovic et al. ACTA NEUROPATHOLOGICA
- Pittsburgh compound B and the postmortem diagnosis of alzheimer disease
- (2012) Dana M. Niedowicz et al. ANNALS OF NEUROLOGY
- In vivo assessment of amyloid-β deposition in nondemented very elderly subjects
- (2012) Chester A. Mathis et al. ANNALS OF NEUROLOGY
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease
- (2012) James D. Doecke ARCHIVES OF NEUROLOGY
- Amyloid-β Immunotherapy for Alzheimers Disease
- (2012) H.J. Fu et al. CNS & Neurological Disorders-Drug Targets
- Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer’s disease pathology
- (2012) Ryuichi Harada et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment
- (2012) V. Camus et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Preclinical Alzheimer disease—the challenges ahead
- (2012) Reisa A. Sperling et al. Nature Reviews Neurology
- Toward a multifactorial model of Alzheimer disease
- (2012) Martha Storandt et al. NEUROBIOLOGY OF AGING
- IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment
- (2012) H. Pruss et al. NEUROLOGY
- CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease
- (2012) R. Tarawneh et al. NEUROLOGY
- Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
- (2012) W. T. Hu et al. NEUROLOGY
- Agonistic Autoantibodies to the α1-Adrenergic Receptor and the β2-Adrenergic Receptor in Alzheimer’s and Vascular Dementia
- (2012) P. Karczewski et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
- (2011) Leslie M. Shaw et al. ACTA NEUROPATHOLOGICA
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Amyloid-beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B data
- (2011) Andrei G. Vlassenko et al. ANNALS OF NEUROLOGY
- Visinin-like protein-1: Diagnostic and prognostic biomarker in Alzheimer disease
- (2011) Rawan Tarawneh et al. ANNALS OF NEUROLOGY
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
- (2011) Victor L. Villemagne et al. ANNALS OF NEUROLOGY
- Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease
- (2011) Adam S. Fleisher ARCHIVES OF NEUROLOGY
- The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease
- (2011) Valerio Leoni CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls
- (2011) Henryk Barthel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Use of Florbetapir-PET for Imaging β-Amyloid Pathology
- (2011) Christopher M. Clark JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias
- (2011) V. L. Villemagne et al. JOURNAL OF NUCLEAR MEDICINE
- Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
- (2011) Henryk Barthel et al. LANCET NEUROLOGY
- Not quite PIB-positive, not quite PIB-negative: Slight PIB elevations in elderly normal control subjects are biologically relevant
- (2011) Elizabeth C. Mormino et al. NEUROIMAGE
- Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease
- (2011) C. M. Roe et al. NEUROLOGY
- Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease
- (2011) M. D. Ikonomovic et al. NEUROLOGY
- Amyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study
- (2011) J. Koivunen et al. NEUROLOGY
- Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
- (2011) Richard J. Perrin et al. PLoS One
- Diagnosis of Alzheimer's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
- (2011) Eric Nagele et al. PLoS One
- A Blood-Based Screening Tool for Alzheimer's Disease That Spans Serum and Plasma: Findings from TARC and ADNI
- (2011) Sid E. O'Bryant et al. PLoS One
- Florbetapir F-18: A Histopathologically Validated Beta-Amyloid Positron Emission Tomography Imaging Agent
- (2011) John Lister-James et al. SEMINARS IN NUCLEAR MEDICINE
- Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects
- (2010) John Q. Trojanowski et al. Alzheimers & Dementia
- 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial
- (2010) Rik Vandenberghe et al. ANNALS OF NEUROLOGY
- Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression
- (2010) Tania Colasanti et al. AUTOIMMUNITY REVIEWS
- Microarray Analysis of Hippocampal CA1 Neurons Implicates Early Endosomal Dysfunction During Alzheimer's Disease Progression
- (2010) Stephen D. Ginsberg et al. BIOLOGICAL PSYCHIATRY
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
- (2010) Rebecca Craig-Schapiro et al. BIOLOGICAL PSYCHIATRY
- Progression of Cerebral Amyloid Load Is Associated with the Apolipoprotein E ε4 Genotype in Alzheimer's Disease
- (2010) Timo Grimmer et al. BIOLOGICAL PSYCHIATRY
- Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer’s disease
- (2010) Ahmadul Kadir et al. BRAIN
- Increased metabolic vulnerability in early-onset Alzheimer’s disease is not related to amyloid burden
- (2010) Gil D. Rabinovici et al. BRAIN
- In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)
- (2010) D. F. Wong et al. JOURNAL OF NUCLEAR MEDICINE
- Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort
- (2010) Shannon L. Risacher et al. NEUROBIOLOGY OF AGING
- Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
- (2010) Christopher C. Rowe et al. NEUROBIOLOGY OF AGING
- Nonlinear time course of brain volume loss in cognitively normal and impaired elders
- (2010) Norbert Schuff et al. NEUROBIOLOGY OF AGING
- Autoantibodies to the adenosine triphosphate synthase play a pathogenetic role in Alzheimer's disease
- (2010) D. Vacirca et al. NEUROBIOLOGY OF AGING
- Ante mortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies
- (2010) Kejal Kantarci et al. NEUROBIOLOGY OF AGING
- Cognition, glucose metabolism and amyloid burden in Alzheimer's disease
- (2010) Ansgar J. Furst et al. NEUROBIOLOGY OF AGING
- Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB
- (2010) S. M. Resnick et al. NEUROLOGY
- 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage
- (2010) J. V. Ly et al. NEUROLOGY
- Putative CSF protein biomarker candidates for amnestic mild cognitive impairment
- (2010) Scott Counts et al. Translational Neuroscience
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- APOEpredicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging
- (2009) John C. Morris et al. ANNALS OF NEUROLOGY
- Cerebrospinal Fluid Biomarkers and Rate of Cognitive Decline in Very Mild Dementia of the Alzheimer Type
- (2009) Barbara J. Snider et al. ARCHIVES OF NEUROLOGY
- Absence of Pittsburgh Compound B Detection of Cerebral Amyloid β in a Patient With Clinical, Cognitive, and Cerebrospinal Fluid Markers of Alzheimer Disease
- (2009) Nigel J. Cairns et al. ARCHIVES OF NEUROLOGY
- Cognitive Decline and Brain Volume Loss as Signatures of Cerebral Amyloid-β Peptide Deposition Identified With Pittsburgh Compound B
- (2009) Martha Storandt et al. ARCHIVES OF NEUROLOGY
- Redox-reactive antiphospholipid antibody differences between serum from Alzheimer's patients and age-matched controls
- (2009) John A. Mcintyre et al. AUTOIMMUNITY
- Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid
- (2009) Timo Grimmer et al. BIOLOGICAL PSYCHIATRY
- Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum
- (2009) Philine Schneider et al. CNS Neuroscience & Therapeutics
- Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
- (2009) Shannon Risacher et al. Current Alzheimer Research
- Validation of Alzheimer’s disease CSF and plasma biological markers: The multicentre reliability study of the pilot European Alzheimer’s Disease Neuroimaging Initiative (E-ADNI)
- (2009) Katharina Buerger et al. EXPERIMENTAL GERONTOLOGY
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Alterations in Regional Brain Volume and Individual MRI-Guided Perfusion in Normal Control, Stable Mild Cognitive Impairment, and MCI-AD Converter
- (2009) Huali Wang et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- Basal Cerebral Metabolism May Modulate the Cognitive Effects of A in Mild Cognitive Impairment: An Example of Brain Reserve
- (2009) A. D. Cohen et al. JOURNAL OF NEUROSCIENCE
- Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease
- (2009) N. Nelissen et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of 18F-FDG and PiB PET in Cognitive Impairment
- (2009) V. J. Lowe et al. JOURNAL OF NUCLEAR MEDICINE
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- In vivo mapping of amyloid toxicity in Alzheimer disease
- (2009) G. B. Frisoni et al. NEUROLOGY
- In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia
- (2009) M. A. Burack et al. NEUROLOGY
- Fibrillar amyloid- burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
- (2009) E. M. Reiman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease
- (2009) N A Verwey et al. ANNALS OF CLINICAL BIOCHEMISTRY
- CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases
- (2008) Jing Zhang et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Brain Volume Decline in Aging
- (2008) Anthony F. Fotenos et al. ARCHIVES OF NEUROLOGY
- Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
- (2008) E. C. Mormino et al. BRAIN
- Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
- (2008) Milos D. Ikonomovic et al. BRAIN
- Alpha- and Gamma-Synuclein Proteins Are Present in Cerebrospinal Fluid and Are Increased in Aged Subjects with Neurodegenerative and Vascular Changes
- (2008) E.B. Mukaetova-Ladinska et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease
- (2008) Yi Li et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Individual cerebral metabolic deficits in Alzheimer’s disease and amnestic mild cognitive impairment: an FDG PET study
- (2008) Angelo Del Sole et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism
- (2008) Christopher C Rowe et al. LANCET NEUROLOGY
- Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease
- (2008) Jari Kankaanpää et al. NEUROBIOLOGY OF DISEASE
- Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls
- (2008) Jonathan H. Morra et al. NEUROIMAGE
- An aberrant protein complex in CSF as a biomarker of Alzheimer disease
- (2008) M. A. Lovell et al. NEUROLOGY
- Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence
- (2008) V. Garibotto et al. NEUROLOGY
- Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease
- (2008) V.L. Villemagne et al. NEUROPSYCHOLOGIA
- Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry
- (2008) G. Chételat et al. NEUROPSYCHOLOGIA
- PET imaging of amyloid deposition in patients with mild cognitive impairment
- (2007) Anton Forsberg et al. NEUROBIOLOGY OF AGING
- Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer’s disease
- (2007) Alexander Drzezga et al. NEUROIMAGE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now